Sya.org
9 MD simulations of compound 2GLP-1GLP-1R
Tian Q, Guo K, Deng J, Zhong Y, Yang L (2022) Effects of SGLT2 inhibitors on haematocrit and haemoglobin levels and the associated cardiorenal benefits in T2DM patients: A meta-analysis
Banni S, Petroni A, Blasevich M, Carta G, Angioni E, Murru E, et al
Praise for Becky Dorner & Associates Gastrointestinal Nutrition: A Primer for Nutrition Professionals Self Study Course Hannah Lowe, DNP, RDN, FNP-C, CDCES Planned Exercise, Physical Activity, and Management of Type 2 Diabetes Course Casey Seiden, MS, RD, CDCES The Science of Super-Aging: Unlocking the Secrets of Longevity Kathleen Pellechia, MS, RDN, PMP Minimum Data Set (MDS) 3.0 RAI Manual v1.17 Course Jane Bennett, MS, RDN, LD Minimum Data Set 3.0 Resident Assessment Instrument Manual v1.19.1 (October 2024) Self-Study Course Doreen Rodo, MEd, RDN, LDN Aimee Shea, MPH, RDN, CCMS, LD
Summary and outlook A summary of the relative risk of adverse events associated with GLP-1RAs is presented in Table 1